Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | HTR2A | P28223 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065416 | 0.82 | — | — | |
| SCHEMBL20968147 | 0.75 | GPR3 (0.46) | GPR3SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL20968137 | 0.68 | POLB (0.36) | SLC6A2SLC6A4SLC6A3 | |
| SCHEMBL19042320 | 0.67 | GPR3 (0.46) | GPR3SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL21065559 | 0.66 | KDM4E (0.41) | SLC6A4 | |
| SCHEMBL17308141 | 0.64 | GPR3 (0.43) | GPR3SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL18827258 | 0.61 | GPR3 (0.40) | GPR3SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL7634193 | 0.61 | EP300 (0.36) | SLC6A2 | |
| SCHEMBL22402767 | 0.59 | GPR3 (0.46) | GPR3SLC6A2SLC6A4SLC6A3HTR2A | |
| SCHEMBL7633875 | 0.59 | ACHE (0.40) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10975184-B2 | High-density ethylene-based polymer using hybrid supported metallocene catalyst and pipe using same | HANWHA CHEMICAL CORPORATION (KR) | 2021-04-13 | — | — | US | disclosed |
| US-10954321-B2 | High-density ethylene-based polymer using supported hybrid metallocene catalyst, and manufacturing method therefor | HANWHA CHEMICAL CORPORATION (KR) | 2021-03-23 | — | — | US | disclosed |
| US-20190169325-A1 | HIGH-DENSITY ETHYLENE-BASED POLYMER USING SUPPORTED HYBRID METALLOCENE CATALYST, AND MANUFACTURING METHOD THEREFOR | HANWHA CHEMICAL CORPORATION (KR) | 2019-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10975184-B2 | High-density ethylene-based polymer using hybrid supported metallocene catalyst and pipe using same | EEF1E1, EPN1, EEF1A1 | GPR3 4771/4885SLC6A2 4768/4885SLC6A4 4490/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.